Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 5, 2006, Pages 594-602

  Ise, Tomoko ^a   Kreitman, Robert J ^a   Pastan, Ira ^a   Nagata, Satoshi ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

B cell differentiation antigen; CD307; Enzyme immunoassay; Hairy cell leukemia; Immunotoxin; Tumor marker

Indexed keywords

CD30 ANTIGEN; CD307 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; IMMUNOTOXIN; MONOCLONAL ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD DONOR; BLOOD SAMPLING; CANCER PATIENT; CELL DIFFERENTIATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE IDENTIFICATION; HAIRY CELL LEUKEMIA; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ASSAY;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOTOXINS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 33646693164     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.115     Document Type: Article

References (15)

1. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, et al. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001;14:277-89.
2. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R. IRTAs: a new family of immunoglobulin-like receptors differentially expressed in B cells. Blood 2002;99:2662-9.
3. Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci USA 2001;98:9772-7.
4. Davis RS, Dennis G Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD, et al. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 2002;190:123-36.
5. Nakayama Y, Weissman SM, Bothwell AL. BXMAS1 identifies a cluster of homologous genes differentially expressed in B cells. Biochem Biophys Res Commun 2001;285:830-7.
6. Ise T, Maeda H, Santora K, Xiang L, Kreitman RJ, Pastan I, et al. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies. Clin Cancer Res 2005;11:87-96.
7. Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, Engel P. Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol 2005;236:6-16.
8. Zola H, Swart B, Nicholson I, Aasted B, Bensussan A, Boumsell L, et al. CD molecules 2005: human cell differentiation molecules. Blood 2005;106:3123-26.
9. Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J 1997;321:265-79.
10. Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc protooncogene product. Mol Cell Biol 1985;5:3610-6.
11. Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, FitzGerald DJ, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N Engl J Med 2001;345:241-7.
12. Helsel DR. Nondetects and data analysis. New York: John Wiley & Sons, 2005:250pp.
13. Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with confidence: confidence intervals and statistical guidelines, 2nd ed. London: BMJ Books, 2000:240pp.
14. Nagata S, Numata Y, Onda M, Ise T, Hahn Y, Lee B, et al. Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay. J Immunol Methods 2004;292:141-55.
15. FDA guidance for industry bioanalytical method validation. Rockville, MD: Center for Drug Evaluation and Research, US Food and Drug Administration, US Department of Health and Human Services, 2001.